EDGAR Filing Documents for 0001104659-22-082266

Form 8-K - Current report:

SEC Accession No. 0001104659-22-082266

Filing Date

2022-07-25

Accepted

2022-07-25 08:46:01

Documents

Period of Report

2022-07-25

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2221625d1_8k.htm iXBRL	8-K	45222
2	EXHIBIT 1.1	tm2221625d1_ex1-1.htm	EX-1.1	45717
3	EXHIBIT 4.1	tm2221625d1_ex4-1.htm	EX-4.1	101578
4	EXHIBIT 4.2	tm2221625d1_ex4-2.htm	EX-4.2	102108
5	EXHIBIT 4.3	tm2221625d1_ex4-3.htm	EX-4.3	89816
6	EXHIBIT 4.4	tm2221625d1_ex4-4.htm	EX-4.4	96980
7	EXHIBIT 5.1	tm2221625d1_ex5-1.htm	EX-5.1	15569
8	EXHIBIT 10.1	tm2221625d1_ex10-1.htm	EX-10.1	269150
9	EXHIBIT 99.1	tm2221625d1_ex99-1.htm	EX-99.1	11972
13	GRAPHIC	tm2221625d1_ex5-1img001.jpg	GRAPHIC	2790
14	GRAPHIC	tm2221625d1_ex5-1img002.jpg	GRAPHIC	1551
	Complete submission text file	0001104659-22-082266.txt		1153398

Data Files

Seq	Description	Document	Type	Size
10	XBRL TAXONOMY EXTENSION SCHEMA	acxp-20220725.xsd	EX-101.SCH	3042
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	acxp-20220725_lab.xml	EX-101.LAB	34476
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	acxp-20220725_pre.xml	EX-101.PRE	22601
16	EXTRACTED XBRL INSTANCE DOCUMENT	tm2221625d1_8k_htm.xml	XML	3607

Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305

Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469

Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)